Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

被引:52
作者
Liu, Jinyan [1 ]
Ewald, Bonnie A. [1 ]
Lynch, Diana M. [1 ]
Nanda, Anjali [1 ]
Surnida, Shawn M. [1 ]
Barouch, Dan H. [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA
关键词
D O I
10.1128/JVI.01348-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Generating broad cellular immune responses against a diversity of viral epitopes is a major goal of current vaccine strategies for human immunodeficiency virus type 1 (HIV-1) and other pathogens. Virus-specific CD8(+) T-lymphocyte responses, however, are often highly focused on a very limited number of immunodominant epitopes. For an HIV-1 vaccine, the breadth of CD8(+) T-lymphocyte responses may prove to be critical as a result of the need to cover a wide diversity of viral isolates in the population and to limit viral escape from dominant epitope-specific T lymphocytes. Here we show that epitope modification strategies can alter CD8(+) T-lymphocyte epitope immunodominance hierarchies elicited by a DNA vaccine in mice. Mice immunized with a DNA vaccine expressing simian immunodeficiency virus Gag lacking the dominant D-b-restricted AL11 epitope generated a marked and durable augmentation of responses specific for the subdominant D-b-restricted KV9 epitope. Moreover, anatomic separation strategies and heterologous prime-boost regimens generated codominant responses against both epitopes. These data demonstrate that dominant epitopes can dramatically suppress the immunogenicity of subdominant epitopes in the context of gene-based vaccines and that epitope modification strategies can be utilized to enhance responses to subdominant epitopes.
引用
收藏
页码:11991 / 11997
页数:7
相关论文
共 25 条
[1]   Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia [J].
Allen, TM ;
O'Connor, DH ;
Jing, PC ;
Dzuris, JL ;
Mothé, BR ;
Vogel, TU ;
Dunphy, E ;
Liebl, ME ;
Emerson, C ;
Wilson, N ;
Kunstman, KJ ;
Wang, XC ;
Allison, DB ;
Hughes, AL ;
Desrosiers, RC ;
Altman, JD ;
Wolinsky, SM ;
Sette, A ;
Watkins, DI .
NATURE, 2000, 407 (6802) :386-390
[2]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[3]   Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity [J].
Barouch, DH ;
Pau, MG ;
Custers, JHHV ;
Koudstaal, W ;
Kostense, S ;
Havenga, MJE ;
Truitt, DM ;
Sumida, SM ;
Kishko, MG ;
Arthur, JC ;
Korioth-Schmitz, B ;
Newberg, MH ;
Gorgone, DA ;
Lifton, MA ;
Panicali, DL ;
Nabel, GJ ;
Letvin, NL ;
Goudsmit, J .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :6290-6297
[4]   Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes [J].
Barouch, DH ;
Kunstman, J ;
Kuroda, MJ ;
Schmitz, JE ;
Santra, S ;
Peyerl, FW ;
Krivulka, GR ;
Beaudry, K ;
Lifton, MA ;
Gorgone, DA ;
Montefiori, DC ;
Lewis, MG ;
Wolinsky, SM ;
Letvin, NL .
NATURE, 2002, 415 (6869) :335-339
[5]   Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys [J].
Barouch, DH ;
Craiu, A ;
Santra, S ;
Egan, MA ;
Schmitz, JE ;
Kuroda, MJ ;
Fu, TM ;
Nam, JH ;
Wyatt, LS ;
Lifton, MA ;
Krivulka, GR ;
Nickerson, CE ;
Lord, CI ;
Moss, B ;
Lewis, MG ;
Hirsch, VM ;
Shiver, JW ;
Letvin, NL .
JOURNAL OF VIROLOGY, 2001, 75 (05) :2462-2467
[6]   T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens [J].
Brehm, MA ;
Pinto, AK ;
Daniels, KA ;
Schneck, JP ;
Welsh, RM ;
Selin, LK .
NATURE IMMUNOLOGY, 2002, 3 (07) :627-634
[7]   Reversal in the immunodominance hierarchy in secondary CD8+ T cell responses to influenza A virus:: Roles for cross-presentation and lysis-independent immunodomination [J].
Chen, W ;
Pang, K ;
Masterman, KA ;
Kennedy, G ;
Basta, S ;
Dimopoulos, N ;
Hornung, F ;
Smyth, M ;
Bennink, JR ;
Yewdell, JW .
JOURNAL OF IMMUNOLOGY, 2004, 173 (08) :5021-5027
[8]   Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes [J].
Frahm, N ;
Kiepiela, P ;
Adams, S ;
Linde, CH ;
Hewitt, HS ;
Sango, K ;
Feeney, ME ;
Addo, MM ;
Lichterfeld, M ;
Lahaie, MP ;
Pae, E ;
Wurcel, AG ;
Roach, T ;
St John, MA ;
Altfeld, M ;
Marincola, FM ;
Moore, C ;
Mallal, S ;
Carrington, M ;
Heckerman, D ;
Allen, TM ;
Mullins, JI ;
Korber, BT ;
Goulder, PJR ;
Walker, BD ;
Brander, C .
NATURE IMMUNOLOGY, 2006, 7 (02) :173-178
[9]   AIDS - Diversity considerations in HIV-1 vaccine selection [J].
Gaschen, B ;
Taylor, J ;
Yusim, K ;
Foley, B ;
Gao, F ;
Lang, D ;
Novitsky, V ;
Haynes, B ;
Hahn, BH ;
Bhattacharya, T ;
Korber, B .
SCIENCE, 2002, 296 (5577) :2354-2360
[10]   Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-Ad5 immunity [J].
Lemckert, AAC ;
Sumida, SM ;
Holterman, L ;
Vogels, R ;
Truitt, DM ;
Lynch, DM ;
Nanda, A ;
Ewald, BA ;
Gorgone, DA ;
Lifton, MA ;
Goudsmit, J ;
Havenga, MJE ;
Barouch, DH .
JOURNAL OF VIROLOGY, 2005, 79 (15) :9694-9701